1 active not recruiting, 1 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Active not recruiting 1, Completed 1 |
Follow Elagolix 200 MG: new trials by email Literature Review of Elagolix 200 MG trials Research Report on Elagolix 200 MG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp Elagolix 200 MG, Placebo or SOC IVF - Infertility, Endometriosis | Phase 3 | Active not recruiting | Yale University | 97 | 2024-03-16 | 2026-06-05 |
| Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis Elagolix 200 MG, Placebo or SOC IVF - Infertility, Endometriosis | Phase 3 | Completed | Yale University | 103 | 2022-03-15 | 2026-06-12 |
Endometriosis (2) · Infertility (2)
Yale University (2)
United States (2)
Emily Jungheim, MD (2) · Heping Zhang, PhD (2) · Hugh Taylor, MD (2) · Nanette Santoro, MD (2) · Steven Young, MD, PhD (2) · Abisola Tepede, PharmD (1) · David Weinberg, PhD (1) · Jim Segars, MD (1)
R01HD100336 (1)